Modern Aesthetics Board Member Reacts to FDA Clearance of New SkinPen Precision Elite

Crown Aesthetics announced the FDA clearance of its new SkinPen Precision Elite. The elevated device advances the SkinPen legacy and continues to position the brand as the highest standard in microneedling, the company said in a press release. 

"We are always looking for ways to improve, and Elite elevates the highest standard in microneedling,” Jeff Bedard, Founder and CEO of Crown Laboratories. “As the pioneer in the category, we are committed to holding that position by listening to our customers and providing thoughtful, industry-leading innovation."

SkinPen received its inaugural FDA-clearance 6 years ago and continues to be the preferred choice for microneedling procedure among providers and patients in the US. 

The SkinPen Precision Elite is set to launch later this year and will be added to Crown Aesthetics portfolio as a premium option for aesthetics partners. 

Modern Aesthetics board member Dr. Doris Day released a statement in support of the device's launch. 

"With the upcoming launch of SkinPen Precision Elite, I commend the brand's dedication to excellence and to enhancing both the provider experience and patient outcomes," Day said. "Microneedling with SkinPen is a powerful method for leveraging the body's natural healing processes to boost collagen production and improve the appearance of acne scars and wrinkles."

The device will enable aesthetic practices to deliver their in-office treatments with even more ease and precision. It’s used for a minimally invasive in-office procedure that rejuvenates the skin from within, improving the appearance of facial acne scars and wrinkles on the neck. 

Provider feedback shows the new Elite offers an upgraded user experience with an easy-to-install RFID cartridge, enhanced patient safety features, active retraction powered by all-new ActiSine technology, and a lifetime warranty. 

For more information visit www.skinpen.com.